2015.11.02
License Agreement Has Been Entered with Cartilize Incorporated
License-Out
We executed a license agreement with Cartilize Incorporated which provides iPS cell-derived chondrocyte products for use in therapeutic applications and research purposes, the license allowing exclusive and non-exclusive rights, respectively, on the patents related to chondrocyte induction and those related to iPS cell technology, for all of which we have been granted a sublicensing right from Kyoto University.